ArthroCare/Opus integration ahead of schedule
This article was originally published in The Gray Sheet
Executive Summary
Coblation RF tissue removal tech developer will complete the transition of Opus Medical's manufacturing operations into its Costa Rica facility during the first half of 2005 following the Nov. 15 purchase of the soft tissue orthopedic repair system maker (1"The Gray Sheet" Nov. 22, 2004, In Brief). During the fourth quarter, ArthroCare brought Costa Rica's Opus production on line and completed planned distribution changes for Opus and Coblation product lines. ArthroCare's preliminary Q4 results include revenue of $42.7 mil., up 31.4%...